FOLH1 and neoplasm: Subsequent studies using murine xenograft models of PCa demonstrated specific and high-level accumulation of radiolabeled PSMA ligands within tumors, resulting in significant, dose-dependent tumor growth inhibition and the induction of DNA damage [59].